Plevris, Nikolas http://orcid.org/0000-0002-3229-8759
Jones, Gareth R.
Jenkinson, Philip W.
Lyons, Mathew
Chuah, Cher S.
Merchant, Lynne M.
Pattenden, Rebecca J.
Watson, Eleanor F.
Ho, Gwo-Tzer
Noble, Colin L.
Din, Shahida
Shand, Alan G.
Arnott, Ian D.
Lees, Charlie W.
Article History
Received: 13 August 2018
Accepted: 29 November 2018
First Online: 7 December 2018
Compliance with ethical standards
:
: NP has received consultancy fees from Takeda and speaker fees and travel support from AbbVie, Takeda and Norgine. EFW has received travel support from AbbVie. SD has received travel support from AbbVie and Dr. Falk. CLN has received consultancy fees from Vifor. AGS has received travel support from AbbVie. IDA has received consultancy fees from Vifor and travel support from Shire. CWL has received research support from AbbVie and Shire, consultancy fees from AbbVie, Pfizer, Dr. Falk, Hospira, MSD, Pharmacosmos, Takeda and Vifor, and speaker fees and travel support from AbbVie, Pfizer, Dr. Falk, Ferring, Hospira, MSD, Shire, Takeda and Warner-Chilcott. GRJ, PWJ, ML, CSC, LMM, RJP, and GTH have no personal interests to declare.
Free to read: This content has been made available to all.